ClinicalTrials.govpublic full text
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
solid tumor, hepatocellular carcinoma, gastric cancer, gastroesophageal junction adenocarcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 363618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.